Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

PetMedix co-founder makes Forbes ‘30 under 30’ list
Dr Jolyon Martin.

Dr Jolyon Martin is the only honouree from an animal health firm

PetMedix co-founder Dr Jolyon Martin has been included in the Forbes 30 Under 30 Europe List for Science and Healthcare 2021.

The 28-year-old head of business development
has been instrumental in translating human health technology breakthroughs into companion animals. 

While undertaking his PhD at the University of Cambridge, Dr Martin developed a transgenic mouse platform that can create fully canine antibodies - technology that now forms the basis of the PetMedix technology.

Dr Martin commented: “I am honoured to be included in the Forbes 30 Under 30 list, and excited to join the global network of fellow entrepreneurs. I’ve always had a passion for animals, having been surrounded by dogs growing up. 

“We also have increasing evidence about the close links between the health and welfare of pets and their human owners. I am thrilled that my work at PetMedix, developing therapeutics to fill a yawning gap in the provision of precision medicine for pets, has been recognised among such outstanding fellow honourees.”  

The Forbes list contains young entrepreneurs across 10 categories who have achieved excellence in their field. Dr Martin is the only honouree from an animal health firm to be included on this year’s list.

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.